1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Heart Transplant Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Heart Transplant Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Target Disease Incidence
- 5.1.2 Growing Geriatric Population
5.2 Market Opportunities
- 5.2.1 Improving Healthcare Capabilities and Growing Patient Pool in Emerging Nations
5.3 Future Trends
- 5.3.1 Growing adoption of AI in heart transplantation procedures are likely to act as future trends for the heart transplant market
5.4 Impact of Drivers and Restraints
6. North America Heart Transplant Market Regional Analysis
6.1 North America Heart Transplant Market Overview
6.2 North America Heart Transplant Market Revenue 2020-2030 (US$ Million)
6.3 North America Heart Transplant Market Forecast Analysis
7. North America Heart Transplant Market Analysis – by Surgery Type
7.1 Orthotopic Heart Transplant and Heterotopic Heart Transplant
- 7.1.1 Overview
- 7.1.2 Orthotopic Heart Transplant and Heterotopic Heart Transplant: North America Heart Transplant Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Heart Transplant Market Analysis – by Type
8.1 Donor Live Heart and Artificial Hearts
- 8.1.1 Overview
- 8.1.2 Donor Live Heart and Artificial Hearts: North America Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Heart Transplant Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Donor Live Heart and Artificial Hearts: North America Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Cardiac Centers
- 9.2.1 Overview
- 9.2.2 Donor Live Heart and Artificial Hearts: North America Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Heart Transplant Market – North America Analysis
10.1 North America
- 10.1.1 North America Heart Transplant Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.1.1.1 North America Heart Transplant Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.1.1 US: North America Heart Transplant Market Breakdown, by Surgery Type
- 10.1.1.1.2 US: North America Heart Transplant Market Breakdown, by Type
- 10.1.1.1.3 US: North America Heart Transplant Market Breakdown, by End User
- 10.1.1.2 Canada:
North America Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.1 Canada: North America Heart Transplant Market Breakdown, by Surgery Type
- 10.1.1.2.2 Canada: North America Heart Transplant Market Breakdown, by Type
- 10.1.1.2.3 Canada: North America Heart Transplant Market Breakdown, by End User
- 10.1.1.3 Mexico :
North America Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.3.1 Mexico : North America Heart Transplant Market Breakdown, by Surgery Type
- 10.1.1.3.2 Mexico : North America Heart Transplant Market Breakdown, by Type
- 10.1.1.3.3 Mexico : North America Heart Transplant Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Heart Transplant Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Terumo Corp
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Evaheart Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Abbott Laboratories
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 SynCardia Systems LLC
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 BiVACOR Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 BioVentrix Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Berlin Heart GmbH
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 LivaNova Plc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Jarvik Heart Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights